Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Head and Neck Cancer

 

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (7797)
A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Investigator: Renato G. Martins, MD, MPH;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01412229

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, or Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Head and Neck Cancer

Investigator: John A. Thompson, MD;   Conditions: Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01727076

MPDL3280A + Cobimetinib for Locally Advanced or Metastatic Cancer
A Phase 1b Study of the Safety and Pharmacology of MPDL3280A Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors

Investigator: Laura Chow, MD;   Conditions: Neoplasms;    Status: Recruiting;   Study ID: NCT01988896

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas (14032)
A Phase 2, Open-Label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck, Lung, or Esophagus (STARRS)

Investigator: Cristina Rodriguez, MD;   Conditions: Advanced Squamous Cell Carcinoma of Head and Neck, Lung, or Esophagus;    Status: Pending;   Study ID: NCT02213133